Pediatric Vouchers Can Have Heavy Adult Involvement, FDA Says
Draft guidance says sponsors remain eligible for rare pediatric disease priority review voucher even if they enroll also adults in clinical trials.
Draft guidance says sponsors remain eligible for rare pediatric disease priority review voucher even if they enroll also adults in clinical trials.